» Articles » PMID: 34859013

Analysis of Risk Factors and Establishment of a Prediction Model for Endoscopic Primary Bile Reflux: A Single-Center Retrospective Study

Overview
Specialty General Medicine
Date 2021 Dec 3
PMID 34859013
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Endoscopic primary bile reflux is one of the main diagnostic criteria for bile reflux gastritis (BRG). Presently, the risk factors and prediction models of endoscopic primary bile reflux (EPBR) in gastropathy patients who cannot or will not undergo endoscopy due to contraindications are not clear. Thus, this study aimed to evaluate the risk factors of EPBR and to establish and verify a prediction model. A series of 844 patients (564 subjects with EPBR and 280 control subjects) were retrospectively selected for this study and divided into a training set ( = 591) and a validation set ( = 253) according to the usual ratio of 70:30% for the subsequent internal validation of the logistic regression model for EPBR. Fifteen parameters that might affect the occurrence of EPBR were collected. Subsequently, univariate and stepwise logistic regression analyses were introduced to reveal the risk factors and the multivariate prediction model. An R package was dedicated to the corresponding internal validation of the EPBR model. The univariate analysis showed that gender, age, smoking, Helicobacter pylori () infection status, metabolic syndrome (MS), non-steroidal anti-inflammatory drugs (NSAIDs) use history, and previous medical histories of chronic liver diseases, cholelithiasis, and erosive gastritis were statistically significant between the two groups ( < 0.05). Multivariate regression described that being a male [OR (95%confidence interval (CI)) = 2.29 (1.50-3.50), < 0.001], age≥45 years old [OR (95% CI) = 4.24 (2.59-6.96), < 0.001], infection status [OR (95% CI) = 2.34 (1.37-4.01), = 0.002], MS [OR (95% CI) = 3.14 (1.77-5.54), < 0.001], NSAIDs use history [OR (95% CI) = 1.87 (1.03-3.40), = 0.04], cholelithiasis history [OR (95% CI) = 3.95 (2.18-7.18), < 0.001] and erosive gastritis history [OR (95% CI) = 6.77 (3.73-12.29), < 0.001] were the risk factors for the occurrence of EPBR. Based on the results of these risk factors, an EPBR prediction model with an adequate calibration and excellent discrimination was established [area under the curve (AUC): 0.839, 95% CI = 0.806-0.872]. Being a male, age ≥ 45 years old, infection, histories of MS, NSAIDs use, cholelithiasis, and erosive gastritis appear to be the risk factors for EPBR, and our favorable prediction model might be an option for the prediction of EPBR.

Citing Articles

Comparative Study for Safety and Efficacy of OAGB and SADJB-SG: A Retrospective Study.

Shang M, Li Z, Du D, Xu G, Lian D, Liao Z Diabetes Metab Syndr Obes. 2024; 17:3499-3508.

PMID: 39319304 PMC: 11420895. DOI: 10.2147/DMSO.S484616.


[Impact of primary duodenogastric reflux and infection on gastritis and antibiotic resistance in children].

Wang X, Lin Q Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(5):493-498.

PMID: 38802910 PMC: 11135063. DOI: 10.7499/j.issn.1008-8830.2311086.


Assessment of the risk factors of duodenogastric reflux in relation to different dietary habits in a Chinese population of the Zhangjiakou area.

Peng Z, Wang R, Wu N, Gao H, Gao H, Li D Food Nutr Res. 2023; 67.

PMID: 37920676 PMC: 10619390. DOI: 10.29219/fnr.v67.9385.


Peri-Ulcerative Mucosal Inflammation Appearance is an Independent Risk Factor for 30-Day Rebleeding in Patients with Gastric Ulcer Bleeding: A Multicenter Retrospective Study.

Bai Y, Lei C, Zhang N, Liu Y, Hu Z, Li Y J Inflamm Res. 2022; 15:4951-4961.

PMID: 36065317 PMC: 9440673. DOI: 10.2147/JIR.S378263.


Pyloric Incompetence Associated with Infection and Correlated to the Severity of Atrophic Gastritis.

Sakaguchi T, Sugihara T, Ohnita K, Fukuda D, Honda T, Ogihara R Diagnostics (Basel). 2022; 12(3).

PMID: 35328125 PMC: 8947545. DOI: 10.3390/diagnostics12030572.

References
1.
Hunt R, Bazzoli F . Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing. Aliment Pharmacol Ther. 2004; 19 Suppl 1:9-16. DOI: 10.1111/j.0953-0673.2004.01830.x. View

2.
Taha A, Angerson W, Morran C . Reflux and Barrett's oesophagitis after gastric surgery--long-term follow-up and implications for the roles of gastric acid and bile in oesophagitis. Aliment Pharmacol Ther. 2003; 17(4):547-52. DOI: 10.1046/j.1365-2036.2003.01430.x. View

3.
Yao X, Smolka A . Gastric Parietal Cell Physiology and Helicobacter pylori-Induced Disease. Gastroenterology. 2019; 156(8):2158-2173. PMC: 6715393. DOI: 10.1053/j.gastro.2019.02.036. View

4.
Alberti K, Zimmet P, Shaw J . The metabolic syndrome--a new worldwide definition. Lancet. 2005; 366(9491):1059-62. DOI: 10.1016/S0140-6736(05)67402-8. View

5.
Dallongeville J, Cottel D, Arveiler D, Tauber J, Bingham A, Wagner A . The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab. 2003; 48(1):43-50. DOI: 10.1159/000075304. View